Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
0%
ALSO IN XDNA
XDNA
3
HOLDINGS
nan%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus XDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
WDNA Overweight Relative to XDNA
| NATERA INC | 4.4% | |
| BRIDGEBIO PHARMA, INC. | 4.0% | |
| BLUEPRINT MEDICINES CORP. | 3.8% | |
| NOVOZYMES A/S-B SHARES | 3.2% | |
| ALNYLAM PHARMACEUTICALS INC | 3.0% | |
| STOKE THERAPEUTICS, INC. | 2.3% | |
| ELI LILLY & CO | 2.3% | |
| UNITED THERAPEUTICS CORP | 2.2% | |
| TWIST BIOSCIENCE CORP. | 2.2% | |
| AGIOS PHARMACEUTICALS INC | 2.1% |
WDNA Underweight Relative to XDNA
| ORIGIN MATERIALS, INC. | 0.2% | |
| MODERNA, INC. | 0.2% | |
| SAREPTA THERAPEUTICS INC | 0.3% | |
| BEYOND MEAT, INC. | 0.3% | |
| ABSCI CORPORATION | 0.3% | |
| ALLOGENE THERAPEUTICS, INC. | 0.3% | |
| VERBIO VEREINIGTE BIOENERGIE AG | 0.3% | |
| SOLVAY SA | 0.4% | |
| PACIFIC BIOSCIENCES OF CALIF | 0.4% | |
| SANA BIOTECHNOLOGY, INC. | 0.4% |